Literature DB >> 22535850

2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.

Sandip M Prasad1, Michael W Drazer, Dezheng Huo, Jim C Hu, Scott E Eggener.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22535850     DOI： 10.1001/jama.2012.534

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

1.  Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support.

Authors:  Jeremy B Shelton; Lee Ochotorena; Carol Bennett; Paul Shekelle; Lorna Kwan; Ted Skolarus; Caroline Goldzweig
Journal:  J Gen Intern Med       Date:  2015-03-05       Impact factor: 5.128

2.  A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.

Authors:  Simon P Kim; R Jeffrey Karnes; Paul L Nguyen; Jeanette Y Ziegenfuss; R Houston Thompson; Leona C Han; Nilay D Shah; Marc C Smaldone; Cary P Gross; Igor Frank; Christopher J Weight; Timothy J Beebe; Jon C Tilburt
Journal:  BJU Int       Date:  2014-01-17       Impact factor: 5.588

3.  Prostate cancer screening practices in a large, integrated health system: 2007-2014.

Authors:  Anita D Misra-Hebert; Bo Hu; Eric A Klein; Andrew Stephenson; Glen B Taksler; Michael W Kattan; Michael B Rothberg
Journal:  BJU Int       Date:  2017-02-26       Impact factor: 5.588

4.  Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result.

Authors:  Ying Shi; Kathy Z Fung; Stephen J Freedland; Richard M Hoffman; Victoria L Tang; Louise C Walter
Journal:  Urology       Date:  2014-10-24       Impact factor: 2.649

5.  Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries.

Authors:  Jonathan K Kish; Mandi Yu; Antoinette Percy-Laurry; Sean F Altekruse
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

6.  Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.

Authors:  Roxanne Espaldon; Katharine A Kirby; Kathy Z Fung; Richard M Hoffman; Adam A Powell; Stephen J Freedland; Louise C Walter
Journal:  Urology       Date:  2014-01-16       Impact factor: 2.649

7.  Five-year downstream outcomes following prostate-specific antigen screening in older men.

Authors:  Louise C Walter; Kathy Z Fung; Katharine A Kirby; Ying Shi; Roxanne Espaldon; Sarah O'Brien; Stephen J Freedland; Adam A Powell; Richard M Hoffman
Journal:  JAMA Intern Med       Date:  2013-05-27       Impact factor: 21.873

8.  Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation.

Authors:  David H Howard; Florence K Tangka; Gery P Guy; Donatus U Ekwueme; Joseph Lipscomb
Journal:  Health Aff (Millwood)       Date:  2013-03       Impact factor: 6.301

9.  Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries.

Authors:  Joseph S Ross; Rong Wang; Jessica B Long; Cary P Gross; Xiaomei Ma
Journal:  Arch Intern Med       Date:  2012-11-12

10.  Ever and Annual Use of Prostate Cancer Screening in African American Men.

Authors:  Chanita Hughes Halbert; Sebastiano Gattoni-Celli; Stephen Savage; Sandip M Prasad; Rick Kittles; Vanessa Briggs; Ernestine Delmoor; LaShanta J Rice; Melanie Jefferson; Jerry C Johnson
Journal:  Am J Mens Health       Date:  2016-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.